Cargando…
HRK inhibits colorectal cancer cells proliferation by suppressing the PI3K/AKT/mTOR pathway
BACKGROUND: As one of the most common malignant tumor, colorectal cancer (CRC) continues to have a high incidence and mortality rate. HRK belongs to the BCL-2 protein family, which has been shown to have antitumor effects in prostate cancer. However, its role in colorectal cancer is not yet known. M...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769574/ https://www.ncbi.nlm.nih.gov/pubmed/36568155 http://dx.doi.org/10.3389/fonc.2022.1053510 |